This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 101/9/948    most recent CIRCRESAHA.107.160630v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hazarika, S. Articles by Annex, B. H. Search for Related Content PubMed PubMed Citation Articles by Hazarika, S. Articles by Annex, B. H. Related Collections Angiogenesis Peripheral vascular disease Type 2 diabetes

(Circulation Research. 2007;101:948.)
© 2007 American Heart Association, Inc.

Integrative Physiology

Impaired Angiogenesis After Hindlimb Ischemia in Type 2 Diabetes Mellitus

Differential Regulation of Vascular Endothelial Growth Factor Receptor 1 and Soluble Vascular Endothelial Growth Factor Receptor 1

Surovi Hazarika, Ayotunde O. Dokun, Yongjun Li, Aleksander S. Popel, Christopher D. Kontos^*, Brian H. Annex^*

From the Division of Cardiology (S.H., A.O.D., Y.L., C.D.K., B.H.A.), Department of Medicine, Durham Veterans Affairs and Duke University Medical Center, NC; and Department of Biomedical Engineering (A.S.P.), Johns Hopkins University School of Medicine, Baltimore, Md.

Correspondence to Brian H. Annex, MD, Division of Cardiology, Duke University and Durham VA Medical Center, 508 Fulton St, Box 111A, Durham, NC 27710. E-mail annex001{at}mc.duke.edu

Deficient angiogenesis after ischemia may contribute to worse outcomes of peripheral arterial disease in patients with diabetes mellitus (DM). Vascular endothelial growth factor (VEGF) and its receptors promote angiogenesis. We hypothesized that in peripheral arterial disease, maladaptive changes in VEGF ligand/receptor expression could account for impaired angiogenesis in DM. Skeletal muscle from diet-induced, type 2 diabetic (DM) and age-matched normal chow (NC)-fed mice was collected at baseline and 3 and 10 days after hindlimb ischemia and analyzed for expression of VEGF (n=10 per group), full-length VEGF receptor (VEGFR)-1, soluble VEGFR-1, and markers of downstream VEGF signaling (n=20 per group) using ELISA, reverse transcriptase-polymerase chain reaction, and Western blots. In the absence of ischemia, DM mice had increased VEGF (NC versus DM: 26.6±2.6 versus 53.5±8.8 pg/mg protein; P<0.05), decreased soluble and membrane-bound VEGFR-1 (NC versus DM: 1.44±0.30 versus 0.85±0.08 and 1.03±0.10 versus 0.72±0.10, respectively; P<0.05), decreased phospho-AKT/AKT and phospho–endothelial NO synthase/endothelial NO synthase (NC versus DM: 0.76±0.2 versus 0.38±0.1 and 0.36±0.06 versus 0.25±0.04, respectively; P<0.05), and no change in VEGFR-2. After ischemia, both DM and NC had comparable increases in VEGF-A. VEGFR-1 and soluble VEGFR-1 expression increased in both groups, but the fold increase was significantly greater in DM. These data demonstrate that soluble VEGFR-1, an angiogenesis inhibitor, is regulated in skeletal muscle by type 2 DM and ischemia. In the absence of ischemia, despite reductions in both soluble VEGFR-1 and VEGFR-1, VEGF ligand signaling is lower in DM compared with controls. After ischemia, maladaptive upregulation of these receptors further reduces the capacity of VEGF to induce an angiogenic response, which may provide a novel target for therapy.

Key Words: vascular disease • growth factors • nitric oxide

This article has been cited by other articles:

				F. T. H. Wu, M. O. Stefanini, F. Mac Gabhann, C. D. Kontos, B. H. Annex, and A. S. Popel Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport Physiol Genomics, June 10, 2009; 38(1): 29 - 41. [Abstract] [Full Text] [PDF]

				N. C. Kappas, G. Zeng, J. C. Chappell, J. B. Kearney, S. Hazarika, K. G. Kallianos, C. Patterson, B. H. Annex, and V. L. Bautch The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching J. Cell Biol., October 20, 2008; 181(5): 847 - 858. [Abstract] [Full Text] [PDF]

				J.-X. Chen and A. Stinnett Disruption of Ang-1/Tie-2 Signaling Contributes to the Impaired Myocardial Vascular Maturation and Angiogenesis in Type II Diabetic Mice Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1606 - 1613. [Abstract] [Full Text] [PDF]

				C. M. Findley, R. G. Mitchell, B. D. Duscha, B. H. Annex, and C. D. Kontos Plasma Levels of Soluble Tie2 and Vascular Endothelial Growth Factor Distinguish Critical Limb Ischemia From Intermittent Claudication in Patients With Peripheral Arterial Disease J. Am. Coll. Cardiol., July 29, 2008; 52(5): 387 - 393. [Abstract] [Full Text] [PDF]

				A. O. Dokun, S. Keum, S. Hazarika, Y. Li, G. M. Lamonte, F. Wheeler, D. A. Marchuk, and B. H. Annex A Quantitative Trait Locus (LSq-1) on Mouse Chromosome 7 Is Linked to the Absence of Tissue Loss After Surgical Hindlimb Ischemia Circulation, March 4, 2008; 117(9): 1207 - 1215. [Abstract] [Full Text] [PDF]